Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1996 2
1997 2
1998 3
2002 3
2003 6
2004 4
2005 7
2006 4
2007 11
2008 7
2009 3
2010 4
2011 2
2012 7
2013 10
2014 9
2015 15
2016 13
2017 18
2018 26
2019 23
2020 18
2021 13
2022 23
2023 16
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis.
Park K, Li Q, Lynes MD, Yokomizo H, Maddaloni E, Shinjo T, St-Louis R, Li Q, Katagiri S, Fu J, Clermont A, Park H, Wu IH, Yu MG, Shah H, Tseng YH, King GL. Park K, et al. Among authors: yokomizo h. Circ Res. 2022 Jul 8;131(2):168-183. doi: 10.1161/CIRCRESAHA.121.319582. Epub 2022 Jun 1. Circ Res. 2022. PMID: 35642564 Free PMC article.
Improved endurance capacity of diabetic mice during SGLT2 inhibition: Role of AICARP, an AMPK activator in the soleus.
Nakamura S, Miyachi Y, Shinjo A, Yokomizo H, Takahashi M, Nakatani K, Izumi Y, Otsuka H, Sato N, Sakamoto R, Miyazawa T, Bamba T, Ogawa Y. Nakamura S, et al. Among authors: yokomizo h. J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2866-2881. doi: 10.1002/jcsm.13350. Epub 2023 Nov 8. J Cachexia Sarcopenia Muscle. 2023. PMID: 37941098 Free PMC article.
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, Machimura H, Shimura H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Tsukamoto S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Muta Y, Takashi Y, Tamura K. Kobayashi K, et al. Among authors: yokomizo h. Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231222837. doi: 10.1177/14791641231222837. Diab Vasc Dis Res. 2023. PMID: 38096503 Free PMC article.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
RECAP study group; Tsukamoto S, Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, Machimura H, Shimura H, Wakui H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Muta Y, Takashi Y, Tamura K. RECAP study group, et al. Among authors: yokomizo h. Diabetes Obes Metab. 2024 Aug;26(8):3248-3260. doi: 10.1111/dom.15652. Epub 2024 May 19. Diabetes Obes Metab. 2024. PMID: 38764356
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Muta Y, Kobayashi K, Toyoda M, Tone A, Suzuki D, Tsuriya D, Machimura H, Shimura H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Tamura K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Tsukamoto S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Takashi Y, Kawanami D. Muta Y, et al. Among authors: yokomizo h. Front Pharmacol. 2024 Mar 27;15:1358573. doi: 10.3389/fphar.2024.1358573. eCollection 2024. Front Pharmacol. 2024. PMID: 38601470 Free PMC article.
Invasion in a heterogeneous world: resistance, coexistence or hostile takeover?
Melbourne BA, Cornell HV, Davies KF, Dugaw CJ, Elmendorf S, Freestone AL, Hall RJ, Harrison S, Hastings A, Holland M, Holyoak M, Lambrinos J, Moore K, Yokomizo H. Melbourne BA, et al. Among authors: yokomizo h. Ecol Lett. 2007 Jan;10(1):77-94. doi: 10.1111/j.1461-0248.2006.00987.x. Ecol Lett. 2007. PMID: 17204119 Review.
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report.
Takashi Y, Toyokawa K, Oda N, Muta Y, Yokomizo H, Fukumoto S, Kawanami D. Takashi Y, et al. Among authors: yokomizo h. Front Endocrinol (Lausanne). 2022 Dec 2;13:1004624. doi: 10.3389/fendo.2022.1004624. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531500 Free PMC article.
240 results